Upload
linette-barton
View
219
Download
0
Tags:
Embed Size (px)
Citation preview
In the name of GOD
11
Treatment of End Stage Heart Treatment of End Stage Heart FailureFailure
Surgical TreatmentsSurgical Treatments
Cardiac Resynchronization Cardiac Resynchronization Treatment(CRT) Treatment(CRT)
22
Surgical Treatment of Heart Surgical Treatment of Heart FailureFailure
CABGs in ischemic cardiomyopathyCABGs in ischemic cardiomyopathy
Mitral valve repair in patients with dilated Mitral valve repair in patients with dilated cardiomyopathycardiomyopathy
Surgical Ventricular reconstruction(Dor Surgical Ventricular reconstruction(Dor procedure)procedure)
Passive Cardiac support DevicePassive Cardiac support Device
Heart TransplantationHeart Transplantation
33
Dor procedure for Ischemic Dor procedure for Ischemic CardiomyopathyCardiomyopathy
Purse string stitch around a nonviable scarred aneurysm to Purse string stitch around a nonviable scarred aneurysm to minimize the excluded area. The residual defect is minimize the excluded area. The residual defect is sometimes covered by a patch made from Dacron, sometimes covered by a patch made from Dacron, pericardium, or an autologous tissue flappericardium, or an autologous tissue flap 44
Dor procedure for Ischemic Dor procedure for Ischemic CardiomyopathyCardiomyopathy
The operation shortens the long axis, but leaves the The operation shortens the long axis, but leaves the short axis length unchanged, producing an increase short axis length unchanged, producing an increase in ventricular diastolic sphericity while the systolic in ventricular diastolic sphericity while the systolic shape becomes more ellipticalshape becomes more elliptical 55
CardiomyoplastyCardiomyoplasty
Cardiomyoplasty, also referred to as Cardiomyoplasty, also referred to as "dynamic cardiomyoplasty," "dynamic cardiomyoplasty,"
Surgical therapy for dilated Surgical therapy for dilated cardiomyopathy in which the latissimus cardiomyopathy in which the latissimus dorsi muscle is wrapped around the heart dorsi muscle is wrapped around the heart and paced during ventricular systole. and paced during ventricular systole.
66
Carpentier peformed the first successful Carpentier peformed the first successful surgery on a humen in 1985surgery on a humen in 1985
CardiomyoplastyCardiomyoplasty
77
Considered Criteria for Surgical Considered Criteria for Surgical RepairRepair
Anteroseptal MI, with dilated left ventricle Anteroseptal MI, with dilated left ventricle (end-diastolic volume index >100 mL/m2)(end-diastolic volume index >100 mL/m2)
Depressed LVEF Depressed LVEF
Left ventricular regional dyskinesis or Left ventricular regional dyskinesis or akinesis >30 percent of the ventricular akinesis >30 percent of the ventricular perimeter, and perimeter, and
Either symptoms of angina, heart failure, Either symptoms of angina, heart failure, or arrhythmias or arrhythmias
88
The following are considered to be relative The following are considered to be relative contraindicationscontraindications
Systolic pulmonary artery pressure >60 Systolic pulmonary artery pressure >60 mmHg mmHg
Severe right ventricular dysfunction Severe right ventricular dysfunction
Regional dyskinesis or akinesis without Regional dyskinesis or akinesis without dilation of the ventricle dilation of the ventricle
99
LV Reconstruction for Non-LV Reconstruction for Non-ischemic Cardiomyopathyischemic Cardiomyopathy
Cardiomyoplasty experience has led to Cardiomyoplasty experience has led to other novel approaches to heart failure. other novel approaches to heart failure.
Observations suggested that some Observations suggested that some patients benefited from the diastolic patients benefited from the diastolic "girdling" effect of the muscle wrap "girdling" effect of the muscle wrap
This observation led to the development of This observation led to the development of the Acorn device and Myosplintthe Acorn device and Myosplint
1010
LV Reconstruction for Non-LV Reconstruction for Non-ischemic Cardiomyopathyischemic Cardiomyopathy
Acorn device Acorn device knitted polyester sock knitted polyester sock that is drawn up and that is drawn up and anchored over the anchored over the ventricles in order to limit ventricles in order to limit left ventricular dilation left ventricular dilation Preliminary data suggest Preliminary data suggest that the device produces that the device produces an improvement in heart an improvement in heart failure symptoms, LVEF, failure symptoms, LVEF, left ventricular end-left ventricular end-diastolic dimension, and diastolic dimension, and quality of lifequality of life
1111
INTRODUCTIONINTRODUCTION
Heart transplantation remains the ultimate Heart transplantation remains the ultimate treatment for heart failuretreatment for heart failure
1212
HEART TRANSPLANTATIONHEART TRANSPLANTATIONACTUARIAL SURVIVAL (1982-2000)
0
20
40
60
80
100
0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17
Years Post-Transplantation
Sur
viva
l (%
)
N=52,195
Half-life =9.1 yearsConditional Half-life = 11.6 years
1313
Who Should Not Be OfferedWho Should Not Be Offereda Heart Transplant?a Heart Transplant?
Irreversible PHTN or pulmonary Irreversible PHTN or pulmonary parenchymal diseaseparenchymal diseaseIrreversible renal or hepatic dysfunctionIrreversible renal or hepatic dysfunctionSevere peripheral or cerebrovascular Severe peripheral or cerebrovascular diseasediseaseIDDM with end-organ damageIDDM with end-organ damageCoexisting cancerCoexisting cancerNon-compliance, addictionNon-compliance, addictionElderly patients (aprox > 70yo)Elderly patients (aprox > 70yo)
1414
Intraaortic Balloon Pump (IABP)Intraaortic Balloon Pump (IABP)
Provides temporary Provides temporary circulatory assistancecirculatory assistance– ↓ ↓ Afterload Afterload – Augments aortic Augments aortic
diastolic pressurediastolic pressure
OutcomesOutcomes– Improved coronary Improved coronary
blood flowblood flow– Improved Improved
perfusion of vital perfusion of vital organsorgans
1515
Ventricular Assist Devices Ventricular Assist Devices (VADs)(VADs)
Copyright © 2007, 2004, 2000, Mosby, Inc., an affiliate of Elsevier Inc. All Rights Reserved.
Ventricular Assist Devices (VADs)
• Indications for VAD therapy• Postcardiotomy cardiogenic shock
• Bridge to recovery or cardiac transplantation
1616
Left ventricular assist device
1717
Cardiac Resynchronization Cardiac Resynchronization Therapy for Heart FailureTherapy for Heart Failure
Patient Selection Patient Selection and Clinical Outcomesand Clinical Outcomes
1818
CRT-Cardiac Resynchronization
TherapyTherapyHOW IT WORKS:
Standard implanted pacemakers - equipped with two wires (or "leads") conduct pacing signals to specific regions of heart (usually at positions A and C). Biventricular pacing devices have added a third lead (to position B) that is designed to conduct signals directly into the left ventricle. Combination of all three lead > synchronized pumping of ventricles, inc. efficiency of each beat and pumping more blood on the whole.
1919
Ventricular DysynchronyVentricular Dysynchrony
Abnormal ventricular conduction resulting Abnormal ventricular conduction resulting in a mechanical delayin a mechanical delay– Wide QRS (IVCD); typically LBBB morphologyWide QRS (IVCD); typically LBBB morphology
– Poor systolic functionPoor systolic function
– Impaired diastolic functionImpaired diastolic function
ECG depicting interventricular conduction delayECG depicting interventricular conduction delay
2020
Cardiac Resynchronization Cardiac Resynchronization TherapyTherapy
GoalsGoals
Improve hemodynamicsImprove hemodynamics
Improve Quality of LifeImprove Quality of Life
2121
Cardiac Resynchronization Cardiac Resynchronization TherapyTherapy
Cardiac resynchronization, Cardiac resynchronization, in association with an in association with an optimized AV delay, optimized AV delay, improves hemodynamic improves hemodynamic performance by forcing the performance by forcing the left ventricle to complete left ventricle to complete contraction and begin contraction and begin relaxation earlier, allowing relaxation earlier, allowing an increase in ventricular an increase in ventricular filling time.filling time.
Coordinate activation of the Coordinate activation of the ventricles and septum.ventricles and septum.
ECG depicting cardiac resynchronizationECG depicting cardiac resynchronization
ECG depicting IVCDECG depicting IVCD
2222
Transvenous ApproachTransvenous Approach– Standard pacing leads in RA and RVStandard pacing leads in RA and RV
– Specially designed left heart lead placed in a left ventricular cardiac vein via Specially designed left heart lead placed in a left ventricular cardiac vein via the coronary sinusthe coronary sinus
Achieving Cardiac Achieving Cardiac ResynchronizationResynchronization
Mechanical Goal: Pace Right and Left VentriclesMechanical Goal: Pace Right and Left Ventricles
Cardiac Resynchronization SystemCardiac Resynchronization System
MIRACLE Study PopulationMIRACLE Study PopulationSymptomatic patients with heart failureSymptomatic patients with heart failure
18 years of age18 years of age
NYHA Functional Class III or IVNYHA Functional Class III or IV
QRS duration QRS duration 130 msec 130 msec
LVEF LVEF 35% by echocardiography 35% by echocardiography
LVEDD LVEDD 55 millimeters (echo measure) 55 millimeters (echo measure)
Stable HF medical regimen for Stable HF medical regimen for 1-month 1-month– ACE-I or substitute, if toleratedACE-I or substitute, if tolerated– β-blocker - stable regimen for β-blocker - stable regimen for 3-months 3-months
Abraham WT, et al. Journal of Cardiac Failure 2000; Vol 6 No. 4.Abraham WT, et al. Journal of Cardiac Failure 2000; Vol 6 No. 4.
2424
THANKS FOR YOUR ATTENTION
2525